We have received information about the availability of these products in the UK and Ireland from the manufacturer, LEO Pharma.
In December 2018, we were contacted by LEO Pharma regarding the availability of Dovobet Ointment (calcipotriol/betamethasone dipropionate) and Dovonex Ointment (calcipotriol) in the UK and Republic of Ireland. Details can be found below.
LEO Pharma has confirmed that Dovobet Ointment 120g is currently out of stock in the UK. It is anticipated that supply should be resumed in January 2019. However, there is currently good stock available of Dovobet Ointment 60g.
It was also confirmed that Dovonex Ointment 30g is currently out of stock in the UK. LEO anticipates that supply should be resumed in January 2019. However, there is currently good stock available of Dovonex Ointment 60g.
If you have any questions or would like further information, the manufacturer can be contacted directly either by phone on 01844 347 333 (selecting '2' from the menu for Medical Information), or by email at email@example.com.
Republic of Ireland
LEO Pharma has confirmed that Dovobet Ointment 30g was discontinued in the Republic of Ireland on 31st October 2018. LEO took this decision for commercial reasons 'to allow us to focus our efforts on innovative solutions that will
ultimately drive better patient outcomes.'
The product is expected to remain available for a short period of time until existing stocks have been exhausted. After this time, Dovobet Ointment will no longer be available in the Republic of Ireland in any of the different pack sizes.
LEO Pharma recommends that anybody affected by this change should 'consult their healthcare professional to discuss the best alternative option based on the clinical judgement of the prescriber in partnership with you after discussing your individual needs.' There are alternative products with the same active pharmaceutical ingredients (API) available.
LEO Pharma also wishes to emphasise that this discontinuation is not due to any safety or quality issues with Dovobet Ointment. Existing stock may still be dispensed by Pharmacists and used by patients.
If you are based in Ireland and have any questions or would like further information, the manufacturer can be contacted directly either by phone on +353 1 490 8924, or by email at firstname.lastname@example.org.
You can find more information about other currently unavailable treatments here